CTRI/2010/091/002962已完成未知
Double blinded Randomized Controlled Study to evaluate the dermatological safety of Odomos Oil and its vehicle by repeated open application sensitivity test on upper and lower limbs of healthy children. - Nil
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •?Healthy children
- •?Subjects age group 2 - 12 year.
- •?Parent/Legally acceptable representatives ready to sign the informed consent.
- •?Subject willing to give the consent (if applicable)
- •?Subjects ready to follow instructions during the study period.
- •?Subjects willing to come for regular follow up.
排除标准
- •?Infection, allergy on the exposed area, that is, upper and lower limbs.
- •?Skin allergy antecedents or atopic subjects
- •?Hyper sensitivity to any component of the tested products
- •?Cutaneous disease which may influence the study result
- •?Chronic illness which may influence the cutaneous state.
- •?Subjects on oral corticosteroid with dose >10mg/day
- •?Subject in an exclusion period or participating in any other cosmetic or therapeutic trial.
- •?Any underlying medical illness including diabetes, liver disease or history of HIV, or any other serious medical illness
研究者
相似试验
已完成
2 期
The effect of oral Channa striatus extract versus Glucosamine sulphate on Knee Osteoarthritis patientsknee osteoarthritisACTRN12615000901505niversiti Sains Malaysia156
已完成
不适用
When a person takes extract of Gelidium elegans, it is study to evaluate the efficacy and safetyKCT0003514Kyung Hee University Hosipital at Gangdong80
已完成
不适用
A Study on the Improvement Effect of extract of Aster sphathulifolius Maxim on Human ApplicatioKCT0005917Kyung Hee University Hospital at Gangdong68
已完成
不适用
Double blind, randomized controlled study to evaluate the efficacy and safety of extract of leaves of Dendropanax morbiferous H. Lev on the glucose metabolismKCT0004672Kyung Hee University Hosipital at Gangdong80
已完成
3 期
A double-blind randomised controlled study to evaluate the effectiveness of orally-dosedPalmitoylethanolamide (PEA) compared to placebo for reducing pain severity and duration of migraines in otherwise healthy participants aged 18 years and olderMigrainesNeurological - Other neurological disordersACTRN12620000598987RDC Global Pty Ltd80